Kariolis, Mihalis S
Miao, Yu Rebecca
Jones, Douglas S II
Kapur, Shiven
Mathews, Irimpan I
Giaccia, Amato J
Cochran, Jennifer R
Article History
Received: 25 March 2014
Accepted: 14 August 2014
First Online: 21 September 2014
Competing interests
: Stanford University holds patent number US8618254 B2, 'Biologic inhibitors for therapeutic targeting the receptor tyrosine kinase AXL', which is related to the work described in this paper, with M.S.K., Y.R.M., D.S.J., A.J.G. and J.R.C. named as inventors. A.J.G. is a founder of Ruga, a company that discovers and develops targeted therapeutics in oncology that has licensed this patent.